triciribine has been researched along with Precursor T-Cell Lymphoblastic Leukemia-Lymphoma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Battistelli, M; Chiarini, F; Cocco, L; Evangelisti, C; Falcieri, E; Martelli, AM; McCubrey, JA; Ognibene, A; Pagliaro, P; Ricci, F; Tazzari, P | 1 |
1 other study(ies) available for triciribine and Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
Article | Year |
---|---|
Preclinical testing of the Akt inhibitor triciribine in T-cell acute lymphoblastic leukemia.
Topics: Autophagy; Caspase 9; Cell Death; Cell Line, Tumor; Cell Survival; Drug Screening Assays, Antitumor; Drug Synergism; Humans; Mechanistic Target of Rapamycin Complex 1; Microscopy, Electron, Transmission; Multiprotein Complexes; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Proteins; Proto-Oncogene Proteins c-akt; Ribonucleosides; Side-Population Cells; TOR Serine-Threonine Kinases; Transcription Factors; Vincristine | 2011 |